Information Provided By: 
Fly News Breaks for July 13, 2015
VRX, ZTS
Jul 13, 2015 | 07:24 EDT
Piper Jaffray views the recent pullback in shares of Zoetis as a buying opportunity ahead of the company's Q2 results on August 4. Piper notes shares of Zoetis are currently 6% lower than before the media reports came out on June 25 that Valeant (VRX) approached the company about a potential buyout. It expects Zoetis to report in-line to slightly better results and keeps an Overweight rating on the name with a $55 price target. Piper calls the recent selloff overdone.
News For ZTS;VRX From the Last 2 Days
ZTS
Apr 23, 2024 | 05:05 EDT
Barclays lowered the firm's price target on Zoetis to $230 from $260 and keeps an Overweight rating on the shares ahead of the Q1 report. The analyst expects the Q1 reports to provide continuing evidence of improvement in generics and biosimilars for the specialty pharmaceuticals group.
